Elevance Health, US0367521038

Elevance Health stock pre-market at EUR 380.20

Published on 10/14/2026 at 07:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Elevance Health stock is at EUR 380.20 pre-market at Lang & Schwarz on October 14, 2026. Third-quarter results are scheduled for October 21, 2026.

Market outlook

  • Elevance Health stock trades pre-market at EUR 380.20 at 7:52 a.m. CEST at Lang & Schwarz on October 14, 2026.
  • Elevance Health is scheduled to release third-quarter results on October 21, 2026, at 6:00 a.m. EDT.
  • The U.S. quote data lists a 52-week high of USD 436.24, 2.57 percent above the USD 425.27 price on October 13, 2026.
Modernes Krankenhaus-Campus mit Glasfassade und Patienten im Eingangsbereich
Elevance Health Krankenversicherungs-Campus US2855211023 zeigt modernen Gebäudeeingang mit weitläufiger Grünanlage unter blauem Himmel, Illustration mit AI erstellt.

Elevance Health stock is at EUR 380.20 pre-market at Lang & Schwarz at 7:52 a.m. CEST on October 14, 2026. The bid is EUR 377.40 and the ask is EUR 383.00. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Elevance Health stock.

What matters today

Elevance Health is scheduled to release third-quarter 2026 results on October 21, 2026, at 6:00 a.m. EDT, according to Business Wire. The U.S. quote data lists a 52-week high of USD 436.24, 2.57 percent above the USD 425.27 price on October 13, 2026. The price-earnings ratio was 18.90 on October 13, 2026.

Market context: Market report S&P 500.

More news and analysis on Elevance Health stock

Disclaimer...

en | US0367521038 | ELEVANCE HEALTH | boerse | 70320667 | bgmi